"Companies and stakeholders across the energy spectrum need to act together and act fast." Photo via Getty Images

Houston is home to some of the nation's largest oil and gas exploration and production firms, making it one of the world’s most important energy capitals. Growing regional support for pioneering clean tech, such as carbon capture, will help achieve the crucial transition to net zero whilst maintaining economic stability, boosting local industries and creating jobs.

According to the International Energy Agency (IEA), North America and Asia Pacific are expected to hold the largest share in carbon capture capacity. North America’s world-leading carbon capture potential comes as no surprise given the nation’s dominance in oil and gas, and ideal geology for sequestration.

The IEA’s recently published World Energy Outlook 2023 depicts a global market that is in transition. With more companies, world leaders and governments recognizing that a shift towards sustainable energy is both inevitable and transformative, the question is no longer whether we switch to clean energy, but rather how soon the transition can happen.

For every $1 in investment spending on fossil fuels globally, $1.8 is now being spent to develop clean energy, according to the IEA. Although the clean energy market has almost doubled in the past five years to reach an estimated $2.8 trillion in 2023, investment needs to hit $4.2 trillion per year by 2030 to achieve the universally shared goal of net zero. The IEA believes around 1 Gigaton of CO2 must be captured in 2030, rising to 6 Gigatons by 2050 to achieve the Net Zero Emissions by 2050 Scenario (termed NZE Scenario). This presents a tremendous opportunity for government stakeholders and the business community in Houston to turbocharge the economy and protect the planet from the impact of climate change.

While volatility around the energy market lingers, sustainable technologies remain one of the most dynamic areas of global energy investment. An essential ingredient to its success is bringing on board innovators, entrepreneurs, corporations, and financiers to ensure technology innovation is front and center in facilitating the clean energy transition.

Carbon capture technology is critical, but energy leaders and hard-to-abate industries are under pressure to move faster. To do that, the carbon capture industry must scale up its deployment and increase adoption if hard-to-abate sectors are to address the 30 percent of global CO2 emissions for which they are responsible. Governments have a pivotal role to play in providing financial, regulatory and policy incentives, facilitating a collaborative environment between financiers, hard-to-abate operators, and clean tech companies. While we are moving in the right direction, there is no room for complacency or procrastination given the short timescales for meaningful action.

Over the past several years, Carbon Clean, a global company that is revolutionizing carbon capture, has enjoyed significant expansion in North America. Following the passage of the Inflation Reduction Act (IRA) in August 2022, we saw huge interest in our modular industrial carbon capture technology almost overnight, resulting in a 64 percent increase in inquiries from the U.S. To meet this booming demand, we have opened a U.S. headquarters in Houston, and have plans to double our U.S. headcount to meet industry requirements for our scalable and cost-effective technology, CycloneCC. In short, the United States is poised to become our biggest market. Given our latest lead investor and partner is Houston-based Chevron New Energies, there is no better place than Houston to drive innovation in the country’s energy sector.

The IRA did more than just bring in new inquiries for our breakthrough technology – it also signaled to the energy sector that the federal government is getting serious about bringing emissions down. The impact of the IRA cannot be overstated, especially for the point-source carbon capture technology pioneered by Carbon Clean. While the IRA involves billions of dollars of public investment, it is set up in such a way that companies must make substantial investments first, acting as a down payment on fostering jobs and ensuring the business community is delivering ambitious climate action. The benefits are being felt locally as well – cities like Houston are at the forefront of what the IRA has to offer, taking advantage of these investments and reducing emissions.

Companies and stakeholders across the energy spectrum need to act together and act fast. With the dramatic growth required for carbon capture to have full effect, it will be essential for government, industry, and innovators to join together to concentrate on a number of projects and clusters. We are confident that with new cutting-edge technology and broad collaboration we can rapidly get the world on the right path to net zero.

———

Prateek Bumb is CTO and co-founder of Carbon Clean and the principal innovator of Carbon Clean’s industrial carbon capture technologies.

This article originally ran on EnergyCapital.
The Ion has announced the latest companies to move into the hub. Photo courtesy of The Ion

The Ion announces new tenants that have recently moved in, expanded within the hub

moving in

Several organizations — from tech startups to a nonprofit — have moved into the Ion recently to either relocate or expand their presence in Houston.

The Ion District announced new tenants today, bringing the total space leased to 86 percent, according to a news release. The recent additions to the Ion include:

  • Carbon Clean announced its new United States HQ last month. The startup’s technology has captured nearly two million tons of carbon dioxide at almost 50 sites around the world.
  • Cognite is a Norwegian software company for asset-heavy industries that turns industrial data into customer value.
  • OpenStax, a Houston-based nonprofit, is publishing openly licensed college textbooks that are free online and low cost in print.
  • Synopic is a California-based startup that's building next-gen depth-enabled cameras to improve visualization and decision making during medical procedures.
  • Houston-based Motif Neurotech, a medical equipment manufacturing startup, is working to develop minimally invasive electronic solutions for mental health.
  • RedSwan CRE, founded in Houston, is a crowdfunding-style investment platform and marketplace of tokenized commercial real estate.
  • Nauticus Robotics, a marine robotics hardtech and software company, recently went public.
  • Rice University’s Office of Innovation and its Nexus Lab, which is under construction and designed for prototyping and scaling-up technologies, is increasing its presence in the Ion.
  • Also noteworthy is the expanded office of Ara Partners, which first moved into the Ion last year. The Houston-based, global private equity firm is focused on investing in carbon decentralization technology.
  • Dallas-headquartered flexible workspace provider Common Desk announced that it would expand its space by nearly 50 percent at the Ion last December.

“Welcoming this amazing lineup of new tenants, across the breadth of sectors they represent, demonstrates that the Ion is the place to be and do business in Houston,” says Jan E. Odegard, executive director of the Ion, in the news release. “By continuing to fill our space with new innovators across all these different offerings, from all around the globe, we’ve become the home for collisions that will create solutions to the biggest problems facing our world today.

"We pride ourselves on advancing the diverse knowledge, teams, technologies, and products that will propel our world forward. Our inspiring new tenants will do just that,” he continues.

The Ion's grand opening took place just about a year ago, and existing tenants include Chevron, Microsoft, (Schlumberger) SLB Innovation Factori, Houston Methodist. The growing Ion District is home to more than 300 businesses, including corporates, small businesses, startups, and restaurants.

“The Ion continues to see leasing demand from companies that understand the value of a creative and active work environment,” says Bryson Grover, investment manager of real estate development at Rice Management Co. “Companies are choosing Ion District because it offers more than just a solution for space needs. Workers are given the opportunity to experience a sense of community that brings together like-minded individuals and those with different perspectives.”

Carbon Clean is moving into the Ion for its United States headquarters. Photo courtesy of the Ion

U.K. carbon capture startup sets up new HQ in Houston

seeing green

A startup that produces carbon capture technology has set up its U.S. headquarters in Houston. Establishment of the HQ marks the company’s formal North American expansion.

Carbon Clean, based in the United Kingdom, says it will double the size of its U.S. workforce to meet greater demand for its CycloneCC technology. The company expects the U.S. to become its biggest market.

The startup’s technology has captured nearly two million tons of carbon dioxide at almost 50 sites around the world. Carbon Clean says CycloneCC can reduce the cost of carbon capture by as much as 50 percent with a footprint that’s 50 percent smaller than traditional carbon capture units.

CycloneCC is ideal for businesses such as cement producers, steelmakers, refineries and waste-to-energy plants, Carbon Clean says.

The U.S. Inflation Reduction Act has driven up demand for industrial carbon capture technology, with Carbon Clean logging a more than 64 percent increase in U.S. inquiries since the act was passed last August.

Aniruddha Sharma, chairman and CEO of Carbon Clean, says passage of the Inflation Reduction Act has made the U.S. “one of the best places in the world to develop industrial carbon capture projects.”

Carbon Clean is no stranger to the U.S. It’s been active in this country for more than four years. Houston-based Chevron New Energies led the company’s $150 million Series C round last May.

“Carbon Clean is experiencing phenomenal growth globally, but we expect our expansion in North America to outpace all other regions. As a result, we intend to establish a very significant base in North America, which will include developing a local supply chain to ensure we are set to ramp up commercialization,” Sharma says in a news release.

On March 8, Carbon Capture hosted a reception and panel discussion at its new HQ. The office is at The Ion, located at 4210 Main St.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”

Houston startup raises $6M to scale home-based healthcare platform

fresh funding

As healthcare systems race to expand care beyond hospitals and into the home, investors are placing bigger bets on the infrastructure needed to make that shift possible.

This month, Rosarium Health announced it has raised $6 million in seed funding led by Kalos Ventures, with participation from ResilienceVC, Rock Health Capital, Symphonic Capital, Black Tech Nations Ventures and others.

The investment will help the Houston-based startup continue to build its platform, which features a national network of 800-plus clinicians and 3,000-plus contractors to coordinate home accessibility upgrades and modifications for seniors and people living with disabilities.

For founder and CEO Cameron Carter, the company’s mission grew out of firsthand caregiving experiences.

“From my own personal caregiving experiences, I realized that the benefits exist on paper, but not in reality,” Carter said in a news release. “Families are being left to figure out the paperwork and installations all on their own, which shouldn’t be how this works.”

While Medicare Advantage and Medicaid plans have expanded coverage for home-based services and accessibility modifications, the logistics behind delivering those services often remain fragmented.

Rosarium’s platform coordinates the entire process, from clinical assessments and referrals to contractor management, documentation, reimbursement and installation.

“A clinician can document that a home isn’t safe and a plan can approve a benefit, but there’s no one that’s responsible for making sure the work actually gets done,” Carter says. “We built the missing piece.”

The company was founded in 2021 as Rose Health and was a 2023 participant in the Texas Medical Center’s Accelerator for HealthTech program. It has scaled quickly, building a network of more than 800 clinicians and 3,000 contractors across 34 states.

Rosarium is currently in-network for 1.2 million Medicare and Medicaid lives, with projected coverage expected to reach nearly 4 million by the end of the year, according to the release.

“We’re excited to back Cameron because he and the team at Rosarium are building the infrastructure healthcare needs right now to make the home a safe and comfortable place of care,” Kate Ballinger, investor at Kalos Ventures, added in the release.

As part of the recent investment, Ballinger will join Rosarium’s board of directors.

With eyes on the future, Rosarium plans to grow its partnerships with Medicaid and Medicare Advantage plans, including CalViva and Community Health Plan of Imperial Valley, strengthening its presence in California while expanding access to underserved communities.

Additionally, Carter predicts that home-based healthcare will be part of a broader transformation happening across the industry.

“There’s a growing recognition that health outcomes are shaped by what happens in the home,” he said in the release. “The future of healthcare isn’t just treating people after something goes wrong. It’s creating environments that help prevent those problems in the first place.”